Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects:

Characteristics of patients who decreased their screen time by more than 60 minutes after the challenge. by Annaëlle Le Steunf (19838110)

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Infection of humanized mice resulted in decrease in pathogenicity in HTLV-1-CTCF infected mice. by Ancy Joseph (5634794)

iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

Prenatal alcohol exposure (PAE) decreases brain and body weights at E14 and P0. by Danielle Sambo (6077924)

Effects of GJE extract treatment decreased expression of NF-kB p65. by Natnicha Suttawong (22367172)

Forest plot of the second endpoint of the clinical symptom improvement. by Jin-Min Gu (17915039)

Subjects:

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. by Shuhuan Zhang (748003)

The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level. by Kaitao Zhao (3617825)

ROBINS-I assessments. by Martha R. Smith (20410184)

Subjects:

S8 File - by Martha R. Smith (20410184)

Subjects:

Study populations of included studies. by Martha R. Smith (20410184)

Subjects:

Future research directions. by Martha R. Smith (20410184)

Subjects:

PRISMA flow diagram. by Martha R. Smith (20410184)

Subjects:

Exercise protocols and results of included studies. by Martha R. Smith (20410184)

Subjects:

Participant characteristics in studies of children with biopsy-proven NAFLD. by Martha R. Smith (20410184)

Subjects:

S9 File - by Martha R. Smith (20410184)

Subjects: